AFGAS
IRWD icon

Allegiance Financial Group Advisory Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.6K Buy
+10,717
New +$43.9K 0.01% 198
2025
Q4 		– Sell
-10,108
Closed -$13.2K – 188
2025
Q3 		$13.2K Buy
+10,108
New +$10.5K ﹤0.01% 164

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Allegiance Financial Group Advisory Services's IRWD Position: Q1 2026 in Review

Allegiance Financial Group Advisory Services opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 10,717 shares worth $37.6K. The stake represents 0.01% of the portfolio and ranks #198 among its holdings. This is a return to the name: Allegiance Financial Group Advisory Services previously reported a position in IRWD as recently as Q3 2025.

Allegiance Financial Group Advisory Services first reported a position in IRWD in Q3 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Allegiance Financial Group Advisory Services held 10,717 shares of Ironwood Pharmaceuticals worth $37.6K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Allegiance Financial Group Advisory Services position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.01% of Allegiance Financial Group Advisory Services's portfolio in Q1 2026, its #198 holding.
  • Allegiance Financial Group Advisory Services first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q1 2026, filed 8 May 2026.